GLSP ameliorates monocrotaline-induced pulmonary arterial hypertension through inhibition of the PI3K/AKT and MAPK signaling pathways
Authors:
- 18 August 2026
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Histology
- Vol. 57 (5) , 275
Abstract
Pulmonary arterial hypertension (PAH) is characterized by pulmonary vascular remodeling and right heart dysfunction, driven largely by excessive proliferation of pulmonary arterial smooth muscle cells (PASMCs). The PI3K/AKT and MAPK signaling pathways are key regulators of this aberrant proliferation. This study investigated whether Ganoderma lucidum spore powder (GLSP), a traditional Chinese medicine with cardiovascular protective effects, ameliorates PAH through modulation of these pathways. In vivo, GLSP administration to monocrotaline (MCT)-induced PAH rats significantly reduced mean pulmonary arterial pressure and right ventricular systolic pressure, attenuated pulmonary vascular wall thickening and fibrosis, and improved right ventricular function, accompanied by suppression of PI3K/AKT and MAPK phosphorylation. In vitro, GLSP reversed PDGFBB-induced PASMC proliferation, migration, and activation of PI3K/AKT and MAPK signaling. Network pharmacology and molecular docking further revealed that GLSP components stably bind to AKT1, SRC, PIK3CA, HSP90AA1, and ESR1—key nodes within these pathways. Our findings, from both in vivo and in vitro experiments, demonstrate that GLSP ameliorates MCT-induced PAH and pulmonary vascular remodeling by inhibiting aberrant PASMC proliferation and migration via suppression of the PI3K/AKT and MAPK signaling axes, highlighting GLSP as a promising therapeutic candidate for PAH. Graphical abstractKeywords
Funding Information
- National Natural Science Foundation of China (No. 82260058)
- Health Commission of Guizhou Province (No. gzwkj2023-130)
- Qian Science and Technology Cooperation Support (No. [2020] 4Y231)
This publication has 62 references indexed in Scilit:
- Heat shock proteins (HSPs) as chaperones for oncogenesis2025
- Circ_0005372 targets the miR-153-3p/ITGB3 axis to stimulate the PI3K/AKT signaling pathway to facilitate the occurrence and development of congenital heart disease and pulmonary arterial hypertension in childrenCardiovascular Pathology, 2025
- Metabolic alterations in human pulmonary artery smooth muscle cells treated with PDGF‐BBAnimal Models and Experimental Medicine, 2024
- Effect of IL‐17 on pulmonary artery smooth muscle cells and connective tissue disease‐associated pulmonary arterial hypertensionImmunity, Inflammation and Disease, 2024
- The Echocardiographic Evaluation of the Right Heart: Current and Future AdvancesCurrent Cardiology Reports, 2023
- CircDiaph3 influences PASMC apoptosis by regulating PI3K/AKT/mTOR pathway through IGF1R3 Biotech, 2023
- Mortality trends in pulmonary arterial hypertension: Are we just spinning our wheels?Pulmonary Circulation, 2022
- Protective effects of dioscin on vascular remodeling in pulmonary arterial hypertension via adjusting GRB2/ERK/PI3K-AKT signalBiomedicine & Pharmacotherapy, 2021
- miR‐22 represses osteoblast viability with ESR1 presenting a direct target and indirectly inactivating p38 MAPK/JNK signalingThe Journal of Gene Medicine, 2020
- A comparison of echocardiography to invasive measurement in the evaluation of pulmonary arterial hypertension in a rat modelThe International Journal of Cardiovascular Imaging, 2010